Talaris Therapeutics Stock Forecast - Polynomial Regression
| TALSDelisted Stock | USD 2.98 0.10 3.25% |
The Polynomial Regression forecasted value of Talaris Therapeutics on the next trading day is expected to be 3.15 with a mean absolute deviation of 0.14 and the sum of the absolute errors of 8.78. Talaris Stock Forecast is based on your current time horizon.
Talaris |
Talaris Therapeutics Polynomial Regression Price Forecast For the 20th of December
Given 90 days horizon, the Polynomial Regression forecasted value of Talaris Therapeutics on the next trading day is expected to be 3.15 with a mean absolute deviation of 0.14, mean absolute percentage error of 0.03, and the sum of the absolute errors of 8.78.Please note that although there have been many attempts to predict Talaris Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Talaris Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Talaris Therapeutics Stock Forecast Pattern
| Backtest Talaris Therapeutics | Talaris Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Talaris Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Talaris Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.6679 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.1439 |
| MAPE | Mean absolute percentage error | 0.0524 |
| SAE | Sum of the absolute errors | 8.7785 |
Predictive Modules for Talaris Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Talaris Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Talaris Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Talaris Therapeutics stock to make a market-neutral strategy. Peer analysis of Talaris Therapeutics could also be used in its relative valuation, which is a method of valuing Talaris Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Talaris Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Talaris Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Talaris Therapeutics shares will generate the highest return on investment. By undertsting and applying Talaris Therapeutics stock market strength indicators, traders can identify Talaris Therapeutics entry and exit signals to maximize returns.
Talaris Therapeutics Risk Indicators
The analysis of Talaris Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Talaris Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting talaris stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.42 | |||
| Semi Deviation | 3.08 | |||
| Standard Deviation | 4.82 | |||
| Variance | 23.24 | |||
| Downside Variance | 12.04 | |||
| Semi Variance | 9.51 | |||
| Expected Short fall | (4.19) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Talaris Stock
If you are still planning to invest in Talaris Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talaris Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |